IONS logo

Ionis Pharmaceuticals, Inc. (IONS) EBIT

Annual EBIT:

-$375.71M-$117.34M(-45.42%)
December 31, 2024

Summary

  • As of today, IONS annual earnings before interest & taxes is -$375.71 million, with the most recent change of -$117.34 million (-45.42%) on December 31, 2024.
  • During the last 3 years, IONS annual EBIT has fallen by -$350.96 million (-1418.15%).
  • IONS annual EBIT is now -206.98% below its all-time high of $351.21 million, reached on December 31, 2019.

Performance

IONS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

Quarterly EBIT:

$144.78M+$270.18M(+215.45%)
June 30, 2025

Summary

  • As of today, IONS quarterly earnings before interest & taxes is $144.78 million, with the most recent change of +$270.18 million (+215.45%) on June 30, 2025.
  • Over the past year, IONS quarterly EBIT has increased by +$188.19 million (+433.48%).
  • IONS quarterly EBIT is now -35.86% below its all-time high of $225.72 million, reached on December 31, 2021.

Performance

IONS Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM EBIT:

-$189.26M+$188.19M(+49.86%)
June 30, 2025

Summary

  • As of today, IONS TTM earnings before interest & taxes is -$189.26 million, with the most recent change of +$188.19 million (+49.86%) on June 30, 2025.
  • Over the past year, IONS TTM EBIT has increased by +$78.67 million (+29.36%).
  • IONS TTM EBIT is now -153.89% below its all-time high of $351.21 million, reached on December 31, 2019.

Performance

IONS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

IONS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-45.4%+433.5%+29.4%
3Y3 Years-1418.2%+241.8%-741.9%
5Y5 Years-207.0%+538.3%-302.0%

IONS EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-1418.2%at lowat high+215.4%-1406.8%+49.9%
5Y5-Year-207.0%at low-35.9%+215.4%-302.0%+49.9%
All-TimeAll-Time-207.0%at low-35.9%+215.4%-153.9%+49.9%

IONS EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
$144.78M(+215.5%)
-$189.26M(+49.9%)
Mar 2025
-
-$125.40M(-46.2%)
-$377.45M(-0.9%)
Dec 2024
-$375.71M(-45.4%)
-$85.77M(+30.2%)
-$374.22M(-38.4%)
Sep 2024
-
-$122.87M(-183.0%)
-$270.37M(-0.9%)
Jun 2024
-
-$43.41M(+64.5%)
-$267.93M(+5.0%)
Mar 2024
-
-$122.17M(-775.6%)
-$282.02M(-9.7%)
Dec 2023
-$258.37M(-3.4%)
$18.08M(+115.0%)
-$256.97M(+18.1%)
Sep 2023
-
-$120.43M(-109.4%)
-$313.66M(-31.2%)
Jun 2023
-
-$57.50M(+40.8%)
-$239.14M(+15.7%)
Mar 2023
-
-$97.12M(-151.6%)
-$283.71M(-13.6%)
Dec 2022
-$249.86M(-909.6%)
-$38.61M(+15.9%)
-$249.84M(-1825.1%)
Sep 2022
-
-$45.91M(+55.0%)
$14.48M(+164.4%)
Jun 2022
-
-$102.08M(-61.4%)
-$22.48M(>-9900.0%)
Mar 2022
-
-$63.25M(-128.0%)
$46.00K(+100.2%)
Dec 2021
-$24.75M(+80.7%)
$225.72M(+372.4%)
-$24.94M(+90.6%)
Sep 2021
-
-$82.87M(-4.2%)
-$266.11M(-25.3%)
Jun 2021
-
-$79.55M(+9.8%)
-$212.36M(-28.0%)
Mar 2021
-
-$88.24M(-471.2%)
-$165.84M(-28.5%)
Dec 2020
-$128.35M(-136.5%)
-$15.45M(+47.0%)
-$129.06M(-237.8%)
Sep 2020
-
-$29.12M(+11.8%)
$93.68M(-32.3%)
Jun 2020
-
-$33.03M(+35.8%)
$138.32M(-16.8%)
Mar 2020
-
-$51.45M(-124.8%)
$166.22M(-52.7%)
Dec 2019
$351.21M(+1219.7%)
$207.29M(+1235.7%)
$351.21M(+111.4%)
Sep 2019
-
$15.52M(+402.1%)
$166.14M(+17.0%)
Jun 2019
-
-$5.14M(-103.8%)
$141.99M(+39.2%)
Mar 2019
-
$133.53M(+500.8%)
$102.02M(+425.3%)
Dec 2018
-$31.37M(-212.1%)
$22.22M(+357.5%)
-$31.36M(+47.0%)
Sep 2018
-
-$8.63M(+80.9%)
-$59.13M(-28.0%)
Jun 2018
-
-$45.10M(>-9900.0%)
-$46.21M(-692.1%)
Mar 2018
-
$141.00K(+102.5%)
$7.80M(-72.1%)
Dec 2017
$27.99M(+249.9%)
-$5.54M(-229.2%)
$27.99M(-71.6%)
Sep 2017
-
$4.29M(-51.8%)
$98.42M(-11.5%)
Jun 2017
-
$8.91M(-56.1%)
$111.23M(+102.8%)
Mar 2017
-
$20.33M(-68.7%)
$54.85M(+393.8%)
Dec 2016
-$18.67M(+63.5%)
$64.89M(+279.5%)
-$18.67M(+87.1%)
Sep 2016
-
$17.10M(+136.0%)
-$145.27M(+23.1%)
Jun 2016
-
-$47.46M(+10.8%)
-$188.91M(-97.0%)
Mar 2016
-
-$53.20M(+13.8%)
-$95.88M(-87.4%)
Dec 2015
-$51.17M(-59.0%)
-$61.71M(-132.5%)
-$51.17M(-252.8%)
Sep 2015
-
-$26.54M(-158.3%)
$33.49M(-15.8%)
Jun 2015
-
$45.56M(+637.0%)
$39.75M(+429.8%)
Mar 2015
-
-$8.48M(-137.0%)
-$12.05M(+62.5%)
Dec 2014
-$32.18M(+31.8%)
$22.95M(+213.2%)
-$32.18M(+56.5%)
Sep 2014
-
-$20.28M(-225.1%)
-$74.00M(+5.9%)
Jun 2014
-
-$6.24M(+78.2%)
-$78.62M(+0.3%)
Mar 2014
-
-$28.61M(-51.6%)
-$78.88M(-67.1%)
Dec 2013
-$47.20M(+11.7%)
-$18.87M(+24.2%)
-$47.20M(-36.6%)
Sep 2013
-
-$24.90M(-283.1%)
-$34.56M(+17.9%)
Jun 2013
-
-$6.50M(-312.5%)
-$42.07M(-33.3%)
Mar 2013
-
$3.06M(+149.1%)
-$31.56M(+40.9%)
Dec 2012
-$53.44M(+21.5%)
-$6.22M(+80.8%)
-$53.44M(+14.0%)
Sep 2012
-
-$32.41M(-907.8%)
-$62.14M(-19.9%)
Jun 2012
-
$4.01M(+121.3%)
-$51.84M(+26.3%)
Mar 2012
-
-$18.81M(-26.0%)
-$70.29M(-3.3%)
Dec 2011
-$68.06M(-42.0%)
-$14.93M(+32.5%)
-$68.06M(-7.0%)
Sep 2011
-
-$22.11M(-53.1%)
-$63.63M(-25.7%)
Jun 2011
-
-$14.44M(+12.9%)
-$50.63M(+12.8%)
Mar 2011
-
-$16.58M(-57.9%)
-$58.08M(-21.2%)
Dec 2010
-$47.93M(-151.0%)
-$10.50M(-15.2%)
-$47.93M(+1.6%)
Sep 2010
-
-$9.12M(+58.4%)
-$48.69M(-0.6%)
Jun 2010
-
-$21.89M(-240.9%)
-$48.42M(-78.9%)
Mar 2010
-
-$6.42M(+43.0%)
-$27.06M(-41.7%)
Dec 2009
-$19.09M(-605.3%)
-$11.26M(-27.4%)
-$19.09M(-33.0%)
Sep 2009
-
-$8.84M(-1546.7%)
-$14.36M(-667.8%)
Jun 2009
-
-$537.00K(-134.6%)
-$1.87M(-191.2%)
Mar 2009
-
$1.55M(+123.7%)
$2.05M(+175.8%)
Dec 2008
-$2.71M(+91.8%)
-$6.53M(-279.1%)
-$2.71M(-292.3%)
Sep 2008
-
$3.64M(+7.7%)
$1.41M(-82.0%)
Jun 2008
-
$3.38M(+205.5%)
$7.82M(+151.4%)
Mar 2008
-
-$3.21M(-32.8%)
-$15.22M(+53.8%)
Dec 2007
-$32.92M
-$2.41M(-124.0%)
-$32.92M(+25.9%)
DateAnnualQuarterlyTTM
Sep 2007
-
$10.06M(+151.2%)
-$44.42M(+39.2%)
Jun 2007
-
-$19.66M(+5.9%)
-$73.02M(-3.3%)
Mar 2007
-
-$20.90M(-50.2%)
-$70.68M(-7.5%)
Dec 2006
-$65.75M(-30.9%)
-$13.91M(+25.0%)
-$65.75M(-8.0%)
Sep 2006
-
-$18.54M(-7.1%)
-$60.87M(-11.0%)
Jun 2006
-
-$17.32M(-8.4%)
-$54.82M(-10.1%)
Mar 2006
-
-$15.98M(-76.9%)
-$49.78M(+0.9%)
Dec 2005
-$50.22M(+41.2%)
-$9.03M(+27.7%)
-$50.22M(+17.1%)
Sep 2005
-
-$12.49M(-1.8%)
-$60.56M(+14.0%)
Jun 2005
-
-$12.27M(+25.3%)
-$70.45M(+11.4%)
Mar 2005
-
-$16.42M(+15.2%)
-$79.51M(+6.9%)
Dec 2004
-$85.43M(-10.7%)
-$19.37M(+13.4%)
-$85.43M(+2.4%)
Sep 2004
-
-$22.38M(-4.9%)
-$87.53M(-3.9%)
Jun 2004
-
-$21.34M(+4.5%)
-$84.22M(-4.5%)
Mar 2004
-
-$22.34M(-4.0%)
-$80.60M(-4.4%)
Dec 2003
-$77.17M(-56.1%)
-$21.48M(-12.7%)
-$77.18M(-17.7%)
Sep 2003
-
-$19.07M(-7.6%)
-$65.57M(-2.4%)
Jun 2003
-
-$17.72M(+6.3%)
-$64.01M(-9.2%)
Mar 2003
-
-$18.91M(-91.6%)
-$58.63M(-18.6%)
Dec 2002
-$49.44M(-7.2%)
-$9.87M(+43.6%)
-$49.44M(-4.6%)
Sep 2002
-
-$17.51M(-41.9%)
-$47.26M(-37.1%)
Jun 2002
-
-$12.34M(-27.0%)
-$34.46M(+10.7%)
Mar 2002
-
-$9.72M(-26.3%)
-$38.59M(+16.3%)
Dec 2001
-$46.10M(-59.0%)
-$7.70M(-63.5%)
-$46.10M(+4.8%)
Sep 2001
-
-$4.71M(+71.4%)
-$48.42M(-11.3%)
Jun 2001
-
-$16.46M(+4.5%)
-$43.50M(-23.5%)
Mar 2001
-
-$17.23M(-72.1%)
-$35.22M(-21.5%)
Dec 2000
-$28.99M(+32.7%)
-$10.01M(-4960.2%)
-$28.99M(+7.9%)
Sep 2000
-
$206.00K(+102.5%)
-$31.48M(+20.9%)
Jun 2000
-
-$8.18M(+25.7%)
-$39.78M(+8.8%)
Mar 2000
-
-$11.01M(+11.9%)
-$43.61M(-1.2%)
Dec 1999
-$43.10M(-32.6%)
-$12.50M(-54.3%)
-$43.10M(-6.9%)
Sep 1999
-
-$8.10M(+32.5%)
-$40.30M(-29.6%)
Jun 1999
-
-$12.00M(-14.3%)
-$31.10M(+3.1%)
Mar 1999
-
-$10.50M(-8.2%)
-$32.10M(+1.5%)
Dec 1998
-$32.50M(-3.8%)
-$9.70M(-981.8%)
-$32.60M(+1.8%)
Sep 1998
-
$1.10M(+108.5%)
-$33.20M(+10.0%)
Jun 1998
-
-$13.00M(-18.2%)
-$36.90M(-9.8%)
Mar 1998
-
-$11.00M(-6.8%)
-$33.60M(-6.7%)
Dec 1997
-$31.30M(-7.6%)
-$10.30M(-296.2%)
-$31.50M(-2.6%)
Sep 1997
-
-$2.60M(+73.2%)
-$30.70M(+11.8%)
Jun 1997
-
-$9.70M(-9.0%)
-$34.80M(-4.8%)
Mar 1997
-
-$8.90M(+6.3%)
-$33.20M(-14.1%)
Dec 1996
-$29.10M(-13.7%)
-$9.50M(-41.8%)
-$29.10M(-12.8%)
Sep 1996
-
-$6.70M(+17.3%)
-$25.80M(+2.6%)
Jun 1996
-
-$8.10M(-68.8%)
-$26.50M(-8.6%)
Mar 1996
-
-$4.80M(+22.6%)
-$24.40M(+5.1%)
Dec 1995
-$25.60M(-13.8%)
-$6.20M(+16.2%)
-$25.70M(+16.3%)
Sep 1995
-
-$7.40M(-23.3%)
-$30.70M(-8.5%)
Jun 1995
-
-$6.00M(+1.6%)
-$28.30M(-4.4%)
Mar 1995
-
-$6.10M(+45.5%)
-$27.10M(-6.3%)
Dec 1994
-$22.50M(-23.0%)
-$11.20M(-124.0%)
-$25.50M(-36.4%)
Sep 1994
-
-$5.00M(-4.2%)
-$18.70M(-3.3%)
Jun 1994
-
-$4.80M(-6.7%)
-$18.10M(-1.1%)
Mar 1994
-
-$4.50M(-2.3%)
-$17.90M(+3.2%)
Dec 1993
-$18.30M(+15.3%)
-$4.40M(0.0%)
-$18.50M(+14.0%)
Sep 1993
-
-$4.40M(+4.3%)
-$21.50M(+2.3%)
Jun 1993
-
-$4.60M(+9.8%)
-$22.00M(-1.9%)
Mar 1993
-
-$5.10M(+31.1%)
-$21.60M(-0.5%)
Dec 1992
-$21.60M(-105.7%)
-$7.40M(-51.0%)
-$21.50M(-12.6%)
Sep 1992
-
-$4.90M(-16.7%)
-$19.10M(-15.1%)
Jun 1992
-
-$4.20M(+16.0%)
-$16.60M(-12.9%)
Mar 1992
-
-$5.00M(0.0%)
-$14.70M(-33.6%)
Dec 1991
-$10.50M(-133.3%)
-$5.00M(-108.3%)
-$11.00M(+8.3%)
Sep 1991
-
-$2.40M(-4.3%)
-$12.00M(-31.9%)
Jun 1991
-
-$2.30M(-76.9%)
-$9.10M(-44.4%)
Mar 1991
-
-$1.30M(+78.3%)
-$6.30M(-40.0%)
Dec 1990
-$4.50M
-$6.00M(-1300.0%)
-$4.50M(-400.0%)
Sep 1990
-
$500.00K(0.0%)
$1.50M(+50.0%)
Jun 1990
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Ionis Pharmaceuticals, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. annual EBIT year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
  • What is Ionis Pharmaceuticals, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Ionis Pharmaceuticals, Inc.?
  • What is Ionis Pharmaceuticals, Inc. TTM EBIT year-on-year change?

What is Ionis Pharmaceuticals, Inc. annual earnings before interest & taxes?

The current annual EBIT of IONS is -$375.71M

What is the all-time high annual EBIT for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $351.21M

What is Ionis Pharmaceuticals, Inc. annual EBIT year-on-year change?

Over the past year, IONS annual earnings before interest & taxes has changed by -$117.34M (-45.42%)

What is Ionis Pharmaceuticals, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of IONS is $144.78M

What is the all-time high quarterly EBIT for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $225.72M

What is Ionis Pharmaceuticals, Inc. quarterly EBIT year-on-year change?

Over the past year, IONS quarterly earnings before interest & taxes has changed by +$188.19M (+433.48%)

What is Ionis Pharmaceuticals, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of IONS is -$189.26M

What is the all-time high TTM EBIT for Ionis Pharmaceuticals, Inc.?

Ionis Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $351.21M

What is Ionis Pharmaceuticals, Inc. TTM EBIT year-on-year change?

Over the past year, IONS TTM earnings before interest & taxes has changed by +$78.67M (+29.36%)
On this page